Working under the umbrella of the PsychENCODE Consortium, the mental health research project established in 2015 by the National Institutes of Health, a team of Mount Sinai scientists has uncovered important new insights into the molecular biology of neuropsychiatric disease through two new studies published in a special issue of Science on Friday, May 24.
Rejuvenate and SAS partner to harness AI for age-related diseases – Pharmaceutical Technology
As people live longer and the ageing population grows, more innovators are entering the field with AI-based solutions. Credit: PeopleImages.com – Yuri A via Shutterstock.
August 2, 2024